Table 2.

Incidence of major (grey) and minor adverse events in primary and revision arthroplasty

	all		pAP		rAP
No adverse events T1	62.1% (218)		66.4% (188)		44.1% (30)
No adverse events T2	89.1% (219)		91.2% (186)		78.6% (33)
Adverse events T1	37.9% (133)		33.6% (95)		55.9% (38)
Adverse events T2	10.9% (27)		8.8% (18)		21.4% (9)
Infection T1	3 / 351	0.9%	1 / 283	0.4%	2 / 68	2.9%
Infection T2	8 / 246	3.3%	5 / 204	2.5%	3 / 42	7.1%
Wound healing disorder T1	3 / 351	0.9%	2 / 283	0.7%	1 / 68	1.5%
Wound healing disorder T2	2 / 246	0.8%	2 / 204	1.0%	0 / 42	0.0%
Further operations T1	5 / 351	1.4%	2 / 283	0.7%	3 / 68	4.4%
Further operations T2	1 / 246	0.4%	1 / 204	0.5%	0 / 42	0.0%
Thrombosis T1	1 / 351	0.3%	0 / 283	0.0%	1 / 68	1.5%
Thrombosis T2	2 / 246	0.8%	2 / 204	1.0%	0 / 42	0.0%
Minor adverse events T1	121 / 351	34.5%	90 / 283	31.8%	31 / 68	45.6%
Minor adverse events T2	14 / 246	5.7%	8 / 204	3.9%	6 / 42	14.3%